JNJ vs SKYX · P/E 17, rev $49.37B vs rev $47.4M
Johnson & Johnson (JNJ) versus SKYX Platforms Corp (SKYX) — a side-by-side from cached financials, not a winner call.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
SKYX Platforms Corp (SKYX) is a electrical equipment & parts company listed on US.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Latest reported SKYX revenue for 2026-06-30 was $47.4M. Net income was -$17.5M. SKYX currently screens at market cap $119.7M.
JNJ currently screens at market cap $375.37B and trailing P/E 17.4. SKYX currently screens at market cap $119.7M.
Not investment advice. Open the JNJ and SKYX stock pages for the full models.
Not investment advice.